Additional studies of PD-L1 protein expression in the tumor were performed in a private laboratory, and the NSCLC showed a positive expression (Ventana, PD-L1, Roche Assay, Roche Diagnostics, Ventana Medical System, Inc., Tucson, AZ, USA). This evidence concerns the gene CD274 and non-small cell lung carcinoma.